John Raemaekers
- Pathology and Forensic Medicine top 0.5%
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Genetics top 1%
- Neurology top 2%
- Co-authors
- Berthe M.P. AlemanJules P.P. MeijerinkAugustinus D. G. KrolAnton HagenbeekPatrice CardeFlora E. van LeeuwenCaroline M.P.W. MandigersMichael Schaapveld
- Topics
- Lymphoma Diagnosis and Treatment (75 papers)Lung Cancer Treatments and Mutations (28 papers)Chronic Lymphocytic Leukemia Research (16 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- NetherlandsBelgiumFrance
In The Last Decade
John Raemaekers
112 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Pathology and Forensic Medicine 2.1k
- Oncology 1.6k
- Pulmonary and Respiratory Medicine 647
- Genetics 616
- Neurology 586
Countries citing papers authored by John Raemaekers
This map shows the geographic impact of John Raemaekers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Raemaekers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Raemaekers more than expected).
Fields of papers citing papers by John Raemaekers
This network shows the impact of papers produced by John Raemaekers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Raemaekers. The network helps show where John Raemaekers may publish in the future.
Co-authorship network of co-authors of John Raemaekers
This figure shows the co-authorship network connecting the top 25 collaborators of John Raemaekers. A scholar is included among the top collaborators of John Raemaekers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Raemaekers. John Raemaekers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 9 | |
| 4 | 5 | |
| 5 | 49 | |
| 6 | 15 | |
| 7 | 197 | |
| 8 | 149 | |
| 9 | 43 | |
| 10 | 49 | |
| 11 | 36 | |
| 12 | 63 | |
| 13 | 13 | |
| 14 | Two hours iv infusion of 2-chlorodeoxyadenosine (2-CDA) in hairy cell leukemia (HCL) is effective and may produce less CD34/CD8 ratio impairment. Results from the HOVON-23 study | 2 |
| 15 | 30 | |
| 16 | 20 | |
| 17 | 7 | |
| 18 | 42 | |
| 19 | 18 | |
| 20 | 16 |
About John Raemaekers
John Raemaekers is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 117 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (75 papers), Lung Cancer Treatments and Mutations (28 papers) and Chronic Lymphocytic Leukemia Research (16 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.1k citations), Genetics (616 citations) and Oncology (1.6k citations). John Raemaekers has collaborated with scholars based in Netherlands, Belgium and France. Frequent co-authors include Berthe M.P. Aleman, Jules P.P. Meijerink, Augustinus D. G. Krol, Anton Hagenbeek, Patrice Carde, Flora E. van Leeuwen, Caroline M.P.W. Mandigers, Michael Schaapveld, Frederika A. van Nimwegen and Evelyn Tönnissen. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.